Lucknow (Uttar Pradesh) [India], May 31 (ANI): A man from Lucknow has filed a police complaint against Serum Institute of India CEO Adar Poonawalla, ICMR director-general Dr Balram Bhargava and others on Tuesday alleging that no antibodies against COVID-19 were developed in his body despi
New Delhi [India], May 31 (ANI): Monoclonal antibodies, recently introduced in India as an antibody therapy to treat COVID-positive patients, are being used to minimise mutation formation and should always be used in a pair, said Dr Nirmal K Ganguly, former Director-General of the Indian Cou
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.
Guntur (Andhra Pradesh) [India], May 29 (ANI): Samishta Hospital and Research Institute (SHRI), Guntur has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh.
Chennai (Tamil Nadu) [India], May 28 (ANI/NewsVoir): A new entrant into the treatment portfolio of COVID-19 in India is the cocktail formulation of Mono Clonal Antibodies (MCAb).
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
New Delhi [India], May 26 (ANI): Fortis Escorts Heart Institute in Delhi is to administer dose of COVID-19 drug cocktail with fast-acting antibodies - Casirivimab and Imdevimab - from tomorrow.
Gurugram (Haryana) [India], May 26 (ANI): An 84-year-old man from Haryana with multiple co-morbidities was discharged from Medanta hospital after getting the jap of monoclonal antibody cocktail. He has become the first person in India to be administered the COVID drug cocktail, which came i
Washington [US], May 25 (ANI): Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19. Such cells could persist for a lifetime, churning out antibodies all the while, suggested a new stud
New Delhi [India], May 22 (ANI): A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test to estimate accurate antibody concentration of COVID-19 in clinical samples, informed the Union Science and Technology Ministry on Saturday.
Moscow [Russia], May 22 (ANI/Sputnik): A study by Japan's Yokohama City University showed that 96 per cent of people previously infected with COVID-19 still had antibodies a year after recovery, Kyodo News Agency reported.
Connecticut [US], May 21 (ANI): A team of scientists discovered novel immune checkpoints that have applications for cancer, autoimmune disease treatment. The immune system is a complex balancing act; if it overreacts or underreacts to foreign molecules, there can be serious health consequenc